Ambrosia Biosciences Inc.
PrivateLast Round
Series B
Mar 31, 2026
Est. Valuation
$203M
Total Funding Raised
$141M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Ambrosia Biosciences Inc. is a biotechnology company developing orally delivered, small molecule-based therapies for obesity and other metabolic disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Ambrosia Biosciences Inc. Comparables
Compare Ambrosia Biosciences Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Eccogene | 89% | |
| Regor Therapeutics Group | 89% | |
| Verdiva Bio | 86% |
Ambrosia Biosciences Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Mar 31, 2026 | ||||
| Series A | Dec 10, 2024 | ||||
| Series A | Aug 20, 2024 |
Key People
Founding team and executive leadership
Ambrosia Biosciences Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Redmile Group | Series B |
| Janus Henderson Group | Series B |
| Blue Owl Capital | Series B |
| Deep Track Capital | Series B |
| BVF Partners L.P. | Series A, Series B |
| Boulder Ventures | Series B, Series A |
| Samsara BioCapital | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2026
Monthly visitors increased 67% MoM.
- Apr 21, 2026
Presenting at the American Diabetes Association's 86th Scientific Session.
Recent news
Latest coverage and updates
- hiresJul 29, 2026
Ambrosia Biosciences Inc. hired Linda as chief medical officer on Jul 1st '26.
- hiresJul 29, 2026
Ambrosia Biosciences Inc. was planning to hire Randy Seeley as board of directors on Jul 1st '26.
- hiresJul 28, 2026
Ambrosia Biosciences Inc. hired Linda Shapiro Manning as chief medical officer on Jul 1st '26.
- hiresJul 28, 2026
Ambrosia Biosciences Inc. hired Randy Seeley as scientific advisory board on Jul 28th '26.
Ambrosia Biosciences Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Ambrosia Biosciences Inc.'s valuation, stock price, and market status.
Is Ambrosia Biosciences Inc. a public or private company?
Ambrosia Biosciences Inc. is a private company.
What is the current stock price of Ambrosia Biosciences Inc.?
Ambrosia Biosciences Inc. is a private company with no public stock price. No recent secondary market data is available.
How much is Ambrosia Biosciences Inc. worth (valuation)?
Valuation information for Ambrosia Biosciences Inc. is not publicly available.
Can I buy Ambrosia Biosciences Inc. stock?
Ambrosia Biosciences Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Ambrosia Biosciences Inc.'s last funding round?
Ambrosia Biosciences Inc.'s most recent funding round was Series B on March 31, 2026.
Who are the main investors in Ambrosia Biosciences Inc.?
Key investors in Ambrosia Biosciences Inc. include Redmile Group, Blue Owl Capital, Deep Track Capital, BVF Partners L.P., Boulder Ventures.
Will Ambrosia Biosciences Inc. IPO soon?
No public IPO plans have been announced for Ambrosia Biosciences Inc..
How can I track Ambrosia Biosciences Inc. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Ambrosia Biosciences Inc.'s secondary market activity and sign up for updates.